Promoting patient safety and improving the quality of patient care
Tag: CMS guidance
ECRI Institute recently released its report, “Top Ten Technology Hazards for 2016”, which noted that failure to effectively monitor postoperative patients for opioid-induced respiratory depression can lead to brain injury or death.
This concern of ECRI is yet another call for improved safety measures for patient’s receiving opioids.
The Physician-Patient Alliance for Health & Safety today issued the following statement encouraging the continuous electronic monitoring of all patients receiving opioids:
To improve patient safety and save patients’ lives, we recommend adopting continuous respiratory monitoring of all patients receiving opioids with pulse oximetry for oxygenation and with capnography for adequacy of ventilation to improve timely recognition of respiratory depression, decompensation or clinical deterioration.
Of the more than 125 articles we posted in 2014, below are 10 of the most read and most discussed articles on opioid safety (order is by publication date).
As you read through these articles, please ask yourself – has a new standard of care been established requiring continuous electronic monitoring by hospitals of all patients receiving opioids? Continue reading “Top 10 Opioid Safety Articles in 2014”
[Editor’s note: This article first appeared in The Doctor Weighs In. The team at Physician-Patient Alliance for Health & Safety thank Pat for her tremendous courage and working with us on this tragic story of what happened to her husband. We hope that in this retelling, hospitals will be encouraged to ensure that similar events become “never events”.] Continue reading “Sleep Apnea + Opioids = Post-Surgical Preventable Death”
by Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety)
[This article first appeared in Patient Safety & Quality Healthcare. To read the full article, please click here.]
In its guidance, “Requirements for Hospital Medication Administration, Particularly Intravenous (IV) Medications and Post-Operative Care of Patients Receiving IV Opioids,” CMS explains the reason behind the issue for this guidance:
By Michael Wong, JD (executive director, Physician-Patient Alliance for Health & Safety)
(This article first appeared in Becker’s Hospital Review.)
On March 14, 2014, CMS issued guidance “Requirements for Hospital Medication Administration, Particularly Intravenous (IV) Medications and Post-Operative Care of Patients Receiving IV Opioids.” Continue reading “New CMS Guidance Recommends Monitoring of All Patients Receiving Opioids”
The Centers for Medicare & Medicaid Services (CMS) issued on March 14, 2014 revised guidance, “Requirements for Hospital Medication Administration, Particularly Intravenous (IV) Medications and Post-Operative Care of Patients Receiving IV Opioids”. Continue reading “CMS Guidance Recommends Monitoring of All Patients Receiving Opioids”